SU458966A3 - Способ получени таблеток - Google Patents
Способ получени таблетокInfo
- Publication number
- SU458966A3 SU458966A3 SU1247008A SU1247008A SU458966A3 SU 458966 A3 SU458966 A3 SU 458966A3 SU 1247008 A SU1247008 A SU 1247008A SU 1247008 A SU1247008 A SU 1247008A SU 458966 A3 SU458966 A3 SU 458966A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- core
- producing tablets
- tablets
- pressure
- ascorbic acid
- Prior art date
Links
- 238000000034 method Methods 0.000 title description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 229960005070 ascorbic acid Drugs 0.000 description 4
- 235000010323 ascorbic acid Nutrition 0.000 description 4
- 239000011668 ascorbic acid Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 3
- -1 white wax Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000000306 component Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000004922 lacquer Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- XQYZDYMELSJDRZ-UHFFFAOYSA-N papaverine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 XQYZDYMELSJDRZ-UHFFFAOYSA-N 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- UOTMYNBWXDUBNX-UHFFFAOYSA-N 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinolin-2-ium;chloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 UOTMYNBWXDUBNX-UHFFFAOYSA-N 0.000 description 1
- CDOUZKKFHVEKRI-UHFFFAOYSA-N 3-bromo-n-[(prop-2-enoylamino)methyl]propanamide Chemical compound BrCCC(=O)NCNC(=O)C=C CDOUZKKFHVEKRI-UHFFFAOYSA-N 0.000 description 1
- 229930008281 A03AD01 - Papaverine Natural products 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000008358 core component Substances 0.000 description 1
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical group CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 description 1
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229960001789 papaverine Drugs 0.000 description 1
- 229960003207 papaverine hydrochloride Drugs 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000012178 vegetable wax Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 229940045860 white wax Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B41/00—After-treatment of mortars, concrete, artificial stone or ceramics; Treatment of natural stone
- C04B41/45—Coating or impregnating, e.g. injection in masonry, partial coating of green or fired ceramics, organic coating compositions for adhering together two concrete elements
- C04B41/50—Coating or impregnating, e.g. injection in masonry, partial coating of green or fired ceramics, organic coating compositions for adhering together two concrete elements with inorganic materials
- C04B41/5025—Coating or impregnating, e.g. injection in masonry, partial coating of green or fired ceramics, organic coating compositions for adhering together two concrete elements with inorganic materials with ceramic materials
- C04B41/5042—Zirconium oxides or zirconates; Hafnium oxides or hafnates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ceramic Engineering (AREA)
- Materials Engineering (AREA)
- Life Sciences & Earth Sciences (AREA)
- Structural Engineering (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR110534A FR1545612A (fr) | 1967-06-15 | 1967-06-15 | Procédé de fabrication de comprimés |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU458966A3 true SU458966A3 (ru) | 1975-01-30 |
Family
ID=8633106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU1247008A SU458966A3 (ru) | 1967-06-15 | 1968-06-14 | Способ получени таблеток |
Country Status (10)
| Country | Link |
|---|---|
| BE (1) | BE716530A (enrdf_load_stackoverflow) |
| DE (1) | DE1767765A1 (enrdf_load_stackoverflow) |
| ES (1) | ES355054A1 (enrdf_load_stackoverflow) |
| FR (1) | FR1545612A (enrdf_load_stackoverflow) |
| GB (1) | GB1233055A (enrdf_load_stackoverflow) |
| IL (1) | IL30165A (enrdf_load_stackoverflow) |
| IT (1) | IT954035B (enrdf_load_stackoverflow) |
| LU (1) | LU56264A1 (enrdf_load_stackoverflow) |
| NL (1) | NL151902B (enrdf_load_stackoverflow) |
| SU (1) | SU458966A3 (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8022032B2 (en) | 2004-11-19 | 2011-09-20 | Smithkline Beecham Corporation | Method for customized dispensing of variable dose drug combination products for individualizing of therapies |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5138412A (en) * | 1974-09-24 | 1976-03-31 | Nippon Kayaku Kk | Kokoseizai no seiho |
| US4076804A (en) * | 1975-07-18 | 1978-02-28 | Abbott Laboratories | Erythromycin therapy |
| SE418247B (sv) * | 1975-11-17 | 1981-05-18 | Haessle Ab | Sett att framstella kroppar med reglerad frigoring av en aktiv komponent |
| US4704284A (en) * | 1982-08-12 | 1987-11-03 | Pfizer Inc. | Long-acting matrix tablet formulations |
| US4503031A (en) * | 1982-12-17 | 1985-03-05 | Glassman Jacob A | Super-fast-starting-sustained release tablet |
| DK62184D0 (da) * | 1984-02-10 | 1984-02-10 | Benzon As Alfred | Diffusionsovertrukket polydepotpraeparat |
| US5032406A (en) * | 1989-02-21 | 1991-07-16 | Norwich Eaton Pharmaceuticals, Inc. | Dual-action tablet |
| US5213807A (en) * | 1990-05-03 | 1993-05-25 | Chemburkar Pramod B | Pharmaceutical composition containing ibuprofen and a prostaglandin |
-
1967
- 1967-06-15 FR FR110534A patent/FR1545612A/fr not_active Expired
-
1968
- 1968-06-12 IL IL30165A patent/IL30165A/en unknown
- 1968-06-13 NL NL686808312A patent/NL151902B/xx unknown
- 1968-06-13 LU LU56264A patent/LU56264A1/xx unknown
- 1968-06-13 BE BE716530D patent/BE716530A/xx unknown
- 1968-06-14 IT IT52034/68A patent/IT954035B/it active
- 1968-06-14 DE DE19681767765 patent/DE1767765A1/de active Pending
- 1968-06-14 SU SU1247008A patent/SU458966A3/ru active
- 1968-06-14 GB GB1233055D patent/GB1233055A/en not_active Expired
- 1968-06-15 ES ES355054A patent/ES355054A1/es not_active Expired
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8022032B2 (en) | 2004-11-19 | 2011-09-20 | Smithkline Beecham Corporation | Method for customized dispensing of variable dose drug combination products for individualizing of therapies |
| US8383579B2 (en) | 2004-11-19 | 2013-02-26 | GlaxoSmithKline, LLC | Method for customized dispensing of variable dose drug combination products for individualizing of therapies |
Also Published As
| Publication number | Publication date |
|---|---|
| DE1767765A1 (de) | 1972-03-30 |
| GB1233055A (enrdf_load_stackoverflow) | 1971-05-26 |
| NL6808312A (enrdf_load_stackoverflow) | 1968-12-16 |
| BE716530A (enrdf_load_stackoverflow) | 1968-11-04 |
| ES355054A1 (es) | 1969-11-16 |
| IL30165A (en) | 1973-04-30 |
| IT954035B (it) | 1973-08-30 |
| FR1545612A (fr) | 1968-11-15 |
| LU56264A1 (enrdf_load_stackoverflow) | 1968-09-23 |
| NL151902B (nl) | 1977-01-17 |
| IL30165A0 (en) | 1968-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU458966A3 (ru) | Способ получени таблеток | |
| KR840005661A (ko) | 지속성 매트릭스 정제 조성물의 제조방법 | |
| GB1019146A (en) | Timed release pharmaceutical preparations and method of making the same | |
| GB1235787A (en) | Sustained release pharmaceutical tablets | |
| KR840006437A (ko) | 항생제 경구 투여용 제형의 제조방법 | |
| US4786507A (en) | Long shelf life tablet containing hydrolysis prone active ingredient | |
| ES264040A1 (es) | Un metodo de fabricaciën de pastillas o granulos para administrar a rumiantes sustancias biolëgicamente activas | |
| ES8102702A1 (es) | Proceso para la preparacion de tabletas farmaceuticas o medicinales de administracion oral, con liberacion retardada delagente activo, en tabletas en las que la cantidad de libera-cion del agente activo es predeterminada. | |
| GB1272640A (en) | Delayed or sustained release medicament dosages and a process for their manufacture | |
| IL34148A (en) | Esters of amino methyl-4-hydroxy-benzyl alcohols,process for their preparation and compositions containing them | |
| US3136695A (en) | Anhydrous thixotropic gel sustained release therapeutic compositions and method of preparation | |
| ES8205353A1 (es) | Un metodo de fabricacion de una composicion farmaceutica de liberacion retardada en formade pastillas que contienen aci-dos acetilsalicilico. | |
| US3493659A (en) | Compositions and process for the production thereof | |
| IL35564A0 (en) | Esters of substituted anthranilic acid,their preparation and pharmaceutical compositions containing them | |
| ES388917A1 (es) | Procedimiento para la produccion de microgranulado solido, esferico, de libre fluencia. | |
| GB1238811A (enrdf_load_stackoverflow) | ||
| ES397668A1 (es) | Mejoras introducidas en un procedimiento para efectuar la interesterificacion de una mezcla de trigliceridos. | |
| JPS51122383A (en) | Semiconductor memory | |
| GB1384887A (en) | Sustained release pharmaceutical tablet | |
| ES419603A1 (es) | Procedimiento para la produccion de tabletas mecanicamente estables y resistentes que contienen una o varias pirazolo- nas y eventualmente compuestos de cafeina. | |
| ES347878A2 (es) | Procedimiento para la preparacion de composiciones tensio- activas. | |
| ES381545A1 (es) | Procedimiento para la obtencion de compuestos de moldeo termoplasticos. | |
| ES361494A1 (es) | Procedimiento para la preparacion de medicamentos con libe-racion prolongada de la sustancia activa. | |
| JPS51148793A (en) | Preparation of polyester | |
| GB1033484A (en) | Process for preparing tablets containing chloral betaine |